Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes
Abstract Background Epidemiological studies of chemotherapy‐induced peripheral neuropathy (CIPN) have predominantly focused on non‐Hispanic White patients, despite the observation that African Americans are more likely to experience CIPN. To address this health disparities gap, we sought to identify...
Guardado en:
Autores principales: | Matthew R. Trendowski, Christine M. Lusk, Julie J. Ruterbusch, Randell Seaton, Michael S. Simon, Mark K. Greenwald, Felicity W. K. Harper, Jennifer L. Beebe‐Dimmer, Ann G. Schwartz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f7126e1a2b374146bee112253b537bb1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
por: Nicolas Kerckhove, et al.
Publicado: (2021) -
Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy
por: Sandy Eldridge, et al.
Publicado: (2021) -
EFFICACY AND SAFETY OF DULOXETINE IN THE TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: I Putu Eka Widyadharma, et al.
Publicado: (2021) -
Managing treatment-related peripheral neuropathy in patients with multiple myeloma
por: Grammatico S, et al.
Publicado: (2016) -
An adolescent rat model of vincristine-induced peripheral neuropathy
por: Ai-Ling Li, et al.
Publicado: (2021)